Company: AIP
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048977
Chunk: 1

Company: Arteris, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
584,272 and 40,724,936 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively43 40 Additional paid-in capital151,377 135,522 Accumulated other comprehensive income258 135 Accumulated deficit(163,127)(136,885)Total stockholders' deficit(11,449)(1,188)TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT$107,737 $106,135 

See accompanying notes to unaudited condensed consolidated financial statements.

3

Table of Contents

Arteris, Inc.

Condensed Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

Three Months EndedSeptember 30,Nine Months Ended September 30,2025202420252024RevenueLicensing, support and maintenance$15,896 $13,507 $46,319 $38,799 Variable royalties and other1,512 1,206 4,123 3,436 Total revenue17,408 14,713 50,442 42,235 Cost of revenue1,766 1,461 5,034 4,387 Gross profit15,642 13,252 45,408 37,848 Operating expenses:Research and development12,648 11,923 36,681 33,475 Sales and marketing6,850 4,962 19,714 15,431 General and administrative4,858 4,286 13,683 13,436 Total operating expenses24,356 21,171 70,078 62,342 Loss from operations(8,714)(7,919)(24,670)(24,494)Interest expense(49)(55)(139)(199)Other income (expense), net636 775 2,140 2,576 Loss before income taxes and loss from equity method investment (8,127)(7,199)(22,669)(22,117)Loss from equity method investment, net of tax484 580 2,079 2,064 Provision for (benefit from) income taxes380 (92)1,494 1,253 Net loss$(8,991)$(7,687)$(26,242)$(25,434)Net loss per share attributable to common stockholders, basic and